Egetis Therapeutics: The US breakthrough designation matters - Redeye
Bildkälla: Stockfoto

Egetis Therapeutics: The US breakthrough designation matters - Redeye

Tiratricol now has US FDA Breakthrough Therapy Designation for MCT8 deficiency, which is essential for several important reasons.

Tiratricol now has US FDA Breakthrough Therapy Designation for MCT8 deficiency, which is essential for several important reasons.
Börsvärldens nyhetsbrev